Thorac Cardiovasc Surg 2012; 60 - V146
DOI: 10.1055/s-0031-1297536

Ross Procedure versus mechanical aortic valve replacement at 10 years? A prospective randomized trial

M Doss 1, S Sirat 1, A Miskovic 1, M Thudt 1, F Detho 1, A Woehrle 1, A Moritz 1
  • 1J.W. Goethe University Hospital Frankfurt, Frankfurt, Germany

Objectives: The objective of this study was to compare long term performance of pulmonary autografts with mechanical aortic valves, in the treatment of aortic valve stenosis.

Methods: From September 1999 to August 2001, fourty patients with aortic valve stenosis, below the age of 55 years, were randomly assigned to receive either pulmonary autografts (n=20) or mechanical valves (Edwards MIRA; Edwards Lifesciences, Irvine, CA) prostheses (n=20). Clinical outcomes, left ventricular mass regression, effective orifice area, ejection fraction, and mean gradients were evaluated at yearly intervals. Follow-up was complete for all patients.

Results:

* p<0.05

Ross

Mira

30 years mortality

n=0

n=0

1 year mortality

n=1

n=1

10 year mortality

n=2 (10%)

n=8 (40%) *

Valve related mortality

n=1

n=5

Bleeding event

n=0

n=5

Mean gradient (mmHg)

2.8±1.3

12±2.6 *

Effective Orifice Area (cm2)

2.6±0.4

1.7±0.6 *

Left ventricular mass index (g/m2)

112±26.1

120±33.5

Embolism

n=1

n=1

Conclusions: At 10 years, patients with pulmonary autografts showed a significantly better hemodynamic performance and less valve related complications than patients with mechanical prostheses, which was reflected by a better survival.